Co-Diagnostics, Inc. (CODX) - Latest Market Data

Price & Market Data

Price: $4.95

Daily Change: +$1.24 / 25.05%

Daily Range: $3.19 - $5.37

Market Cap: $18,542,918

Daily Volume: 10,017,872

Performance Metrics

1 Week: 156.6%

1 Month: 120.1%

3 Months: 52.46%

6 Months: -62.99%

1 Year: -51.14%

YTD: -27.20%

About Co-Diagnostics, Inc. (CODX)

Get up-to-date information on Co-Diagnostics, Inc. (CODX). The stock is trading at 4.95, with a daily performance indicating a change of +$1.24 / 25.05%. Its market cap is recorded at 18,542,918. Delve into detailed performance metrics, from short-term (1-week) to long-term (1-year) and year-to-date returns.

Company Details

Employees: 115

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.

Selected stocks

RenX Enterprises Corp. (RENX)

XCHG Limited (XCH)

Virtus Stone Harbor Emerging Markets Income Fund (EDF)

Marker Therapeutics, Inc. (MRKR)

Elong Power Holding Limited (ELPW)